The prevalence of several clinical and laboratory features (immunoglobulins, anemia, renal dysfunction, elevated calcium level, elevated β2-microglobulin, LDH level, incidence of second tumors, progression to different hematological diseases) differed between MGUS-NN and MGUS-N (Table 1). This evidence concerns the gene HLA-G and hematologic disorder.